Thrivent Financial For Lutherans Agios Pharmaceuticals, Inc. Transaction History

Thrivent Financial For Lutherans

$51.6 Billion
Q4 2024

A detailed history of Thrivent Financial For Lutherans transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 17,526 shares of AGIO stock, worth $546,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,526

Previous 24,603 28.76%

Holding current value

$546,811

Previous $1.09 Million 47.3%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$32.86 - $61.64 $232,550 - $436,226	-7,077 Reduced 28.76%	17,526 $576,000
Q2 2024 Aug 13, 2024	SELL	$27.55 - $48.83 $28,955 - $51,320	-1,051 Reduced 4.1%	24,603 $1.06 Million
Q4 2023 Feb 14, 2024	SELL	$19.97 - $24.53 $382,445 - $469,774	-19,151 Reduced 42.74%	25,654 $572,000
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $535 - $619	22 Added 0.05%	44,805 $1.11 Million
Q2 2023 Aug 14, 2023	SELL	$21.38 - $29.19 $46,950 - $64,101	-2,196 Reduced 4.67%	44,783 $1.27 Million
Q4 2022 Feb 08, 2023	SELL	$24.81 - $31.52 $13,992 - $17,777	-564 Reduced 1.19%	46,979 $1.32 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $1.09 Million - $1.9 Million	-55,776 Reduced 53.98%	47,543 $1.34 Million
Q2 2022 Aug 16, 2022	BUY	$17.06 - $31.42 $1.76 Million - $3.25 Million	103,319 New	103,319 $2.29 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $15.5 Million - $20.2 Million	-350,768 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $2.88 Million - $4.04 Million	86,829 Added 32.9%	350,768 $15.2 Million
Q3 2020 Nov 10, 2020	SELL	$33.87 - $55.93 $241,120 - $398,165	-7,119 Reduced 2.63%	263,939 $9.24 Million
Q2 2020 Aug 12, 2020	BUY	$34.45 - $53.48 $47,782 - $74,176	1,387 Added 0.51%	271,058 $14.5 Million
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $29,565 - $50,473	938 Added 0.35%	269,671 $9.57 Million
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $870,635 - $1.46 Million	28,944 Added 12.07%	268,733 $12.8 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $7.77 Million - $11.9 Million	239,789 New	239,789 $7.77 Million

Others Institutions Holding AGIO

# of Institutions

244

Shares Held

59.9M

Call Options Held

270K

Put Options Held

332K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.71B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Agios Pharmaceuticals, Inc. Transaction History